Health Insurance Companies

The promise of personalized medicine is better healthcare at lower costs. We focus on developing diagnostic assays that help to select the right treatment for the right patient.

Preliminary health economics studies have shown that the application of the AMLprofiler in standard patient care reduces overall treatment costs by preventing overtreatment. The selection of optimal therapies for individual AML patients helps to increase the quality of life as well. Please contact us for the latest information about health economics and our diagnostic products.